Problems viewing this newsletter? View it in your browser >

February 27, 2014

Dear Advocate,

Earlier this week, AVAC kicked off its Research & Reality series, a year-long dialogue about prevention research and advocacy. The first discussion centered on the recently released AVAC Report and an overview of advocacy priorities in 2014 (links to the slides and recording are below). And we are delighted to announce the next in the series — Facing questions about hormonal contraceptives and HIV: What's next in getting answers — Monday, March 10 at 10am Eastern, 4pm South Africa and 5pm in East Africa. (Please note that the US switches to Daylight Savings Time on March 9; check for the time in your area.)

Click to register.

The call will provide a forum to learn about and discuss proposed research to directly evaluate how different family planning methods might impact HIV risk. Trial designs are actively being discussed and funding is being sought for such research—but there are many questions where advocates' voices are needed: What should a trial look like? How can method mix (the range of available family planning options) be expanded for all women? What can be done to better integrate HIV and family planning in the meantime?

Since decisions about potential trials are expected in the coming months, your input and questions are urgently needed.

For an idea of some of the other issues we’re tracking in 2014, see our advocacy timeline and download the slides and recording of the first discussion: What to expect in 2014—where should prevention advocates put their energy? [Audio – MP3; slides – PDF, animation – Flash]

We also want to hear your ideas, opinions and questions to help shape the conversation. Please join us for this call and also email us at with questions, comments and suggestions.

For more information on the series, AVAC’s 2014 advocacy timeline, links to register for upcoming webinars and archives of past calls, please visit


Forward This IssueDo you know someone who might be interested in receiving this newsletter?
Forward > 

Unsubscribe You're receiving this because you signed up for our newsletter. Not interested any longer?
Unsubscribe > 

Contact Us T: +1 212 796 6423